Methods
We undertook an institutional review board-approved retrospective analysis of all cases involving patients who underwent cranioplasty after craniectomy for vascular causes of raised intracranial pressure at Oregon Health & Science University between January 2001 and December 2010. Patients were identified from coding and billing data using Current Procedural Terminology codes (62140, 62141, 62142, 62143, 62145, 62146, and 62147). Electronic medical records were reviewed to determine the reason for craniectomy. Patients who underwent cranioplasty after craniectomy for raised intracranial pressure due to ischemic stroke, nontraumatic intraparenchymal hemorrhage, aneurysmal subarachnoid hemorrhage, AVM rupture, or venous sinus thrombosis were selected for inclusion in the study. Patients were excluded if they had undergone cranioplasty for craniectomies for other causes, including trauma, infected bone flaps after tumor surgery, skull tumors, skull fracture, and craniosynostosis repair.
The following data were collected from the medical record of each patient: age at cranioplasty, sex, indications for craniectomy, laterality of craniectomy, GOS score at time of cranioplasty, time interval between craniectomy and cranioplasty, type of cranioplasty prosthesis (autograft or synthetic), presence of a VP shunt, use of surgical subgaleal drains, operative time, and follow-up time. Each medical chart was also evaluated for postoperative surgical complications, which we defined as complications requiring a return trip to the operating room with the following specific definitions. A hematoma was defined as an epidural or subdural hematoma with clinical signs and symptoms of increased intracranial pressure with or without midline shift on postoperative CT scan. Infection was defined as a surgical-site infection with signs and symptoms of infection (fever, erythema, drainage at the surgical site, elevated white blood cell count) with or without CT imaging characteristics consistent with infection. All patients with infection complications underwent reoperation with removal of the cranioplasty flap followed by treatment with a several-week course of intravenous antibiotic therapy tailored to culture results. Hydrocephalus was defined as clinical signs and symptoms of hydrocephalus (headache, nausea, decreased mental status) with ventriculomegaly on imaging requiring treatment with a CSF shunt. Bone resorption was defined as clinically significant erosion of the bone flap that could be palpated or seen on follow-up imaging and was a concern for patient safety and cosmesis. Although the exact follow-up time was not consistent among patients, all patients were seen at least one time in follow-up within 3 months of cranioplasty.
Patients were divided into 2 cohorts, early and late, based on the median time to cranioplasty for all patients (median 10 weeks; determined after data collection). The early cohort consisted of patients who underwent cranioplasty within 10 weeks of craniectomy. The late (≥ 10 weeks) cohort included all other patients. Demographic, clinical, and outcome data were compared between these 2 cohorts.
Statistical analysis was performed using Stata (StataCorp LP). Data were recorded as numbers and proportions. Associations of categorical variables were compared using the chi-square test or Fisher exact test (when expected numbers were less than 5). Associations between continuous variables were compared using the unpaired, 2-tailed Student t-test. The associations between the outcomes and effect variables were adjusted for confounding factors using logistic regression models. Significance was established at the 95% level.
Results
We identified 74 patients who had undergone cranioplasty after craniectomy for vascular causes of raised intracranial pressure between 2001 and 2010. The mean age for these patients was 47 years (range 5-79 years) and the mean time to cranioplasty was 13 weeks (range 1-59 weeks). The mean follow-up time after cranioplasty for all patients was 13 months (range 1-82 months).
There were 37 patients in the early cohort (cranioplasty within 10 weeks of craniectomy) and 37 patients in the late cohort. The mean time (± SD) to cranioplasty in the early cohort was 35 ± 21 days (range 5-69 days). In the late cohort, the mean time to cranioplasty was 154 ± 70 days (range 70-415 days). There was no statistically significant difference in age, sex, GOS at time of cranioplasty, type of implant (autograft or synthetic), presence of VP shunt, use of surgical subgaleal drains, length of operative time, disposition after cranioplasty, or length of follow-up between the cohorts ( Table 1 ). The early cohort had a higher percentage of patients with AVM rupture than the late cohort (27.0% early, 8.1% late, p = 0.0325).
The patients' functional and clinical status at the time of cranioplasty was evaluated using GOS scores as well as their living situation prior to cranioplasty (home, rehabilitation facility, nursing facility, or hospital). The mean GOS score at time of cranioplasty was similar between the 2 cohorts (3.3 early, 3.1 late, p = 0.3982), although the early cohort had twice as many patients with a good clinical status, which we defined as a GOS score of 4 or 5 (12 early, 6 late, p = 0.1042). More than half the patients in both cohorts were living at home at the time of cranioplasty (51.3% early, 54.1 late, p = 0.8231).
Comparison of the complication rates between the early and late cohorts revealed no statistically significant difference (21.6% early, 16.2% late, p = 0.5541) ( Table 2 ). The rates of infection (13.5% early, 8.1% late, p = 0.7106) and epidural hematoma (2.7% early vs 5.4% late, p = 0.5637) did not differ significantly between the 2 cohorts. The rates of hydrocephalus and bone graft resorption were also similar in the 2 cohorts.
Logistic regression analysis was performed using age category (< 65 years of age or ≥ 65 years of age), time to cranioplasty (< 10 or ≥ 10 weeks), sex, type of cranioplasty material (autologous or synthetic), presence of a VP shunt at the time of cranioplasty, or use of subgaleal surgical drains to determine predictors of infection or any complication as possible factors (Table 3) . Presence of a VP shunt was the only significant predictor of a complication (OR 8.96, 95% CI 1.84-43.6, p = 0.0067) and also the only significant predictor of infection (OR 7.81, 95% CI 1.47-41.6, p = 0.0160).
Discussion
This study revealed no significant difference in complication rates between performing cranioplasty early (within 10 weeks of craniectomy) or late in patients undergoing craniectomy for vascular causes of raised intracranial pressure. The overall complication rate for these patients was 18.9%, which is similar to that in other series of cranioplasty patients (Table 4) . [1] [2] [3] 5, 7, 12, 14, 16 Age, time interval between craniectomy and cranioplasty, sex, use of autograft or synthetic implant, and use of a surgical subgaleal drain did not predict complications. The one significant predictor of complications in this study was presence of a VP shunt at the time of cranioplasty. This study suggests that early cranioplasty does not carry an excessively higher complication risk when compared with delayed cranioplasty after craniectomy for vascular causes. Early cranioplasty may carry some advantages compared with delayed cranioplasty that were not explicitly analyzed in this study. There may be a lower overall cost if patients undergo cranioplasty within the same hospitalization as craniectomy if the risk of malignant intracranial hypertension has passed. Another possible advantage to early cranioplasty is the decreased time at risk for another injury for patients recovering without a bone flap in place. Rehabilitation therapists may be overly cautious in their recovery efforts while the patient is without a bone flap. Some studies have shown improved level of consciousness after cranioplasty, 11 and in these patients early cranioplasty may hasten recovery. Most previous studies of cranioplasty involve trauma patients, who tend to be younger and healthier than the patients with vascular disease studied here. Surprisingly, there were no complications in patients 65 years of age or older in our study. A trend toward higher rates of hydrocephalus with a longer time interval between craniectomy and cranioplasty was shown in one study of 17 stroke patients undergoing cranioplasty, 16 but this was not observed in our study.
Factors that led to timing of cranioplasty for this group of patients were not taken into consideration in the analysis. The cases were selected from a retrospective review of 10 years of data at one institution; overall, the procedures were performed by 11 surgeons with varied practices in terms of managing patients after craniectomy, which also subjects results to a bias risk. A review of the data revealed that 3 surgeons (coauthors A.D., N.D.C., and J.B.D.) performed 75% of all the cranioplasty procedures, and their role was equally balanced between the 2 cohorts (73% early, 84% late, p = 0.5994). While the reasons surgeons selected early or late cranioplasty for each individual patient were not analyzed, some factors that are used to determine appropriate timing include the clinical and functional status of the patient, absence of residual cerebral edema, and healing status of the craniectomy incision. Additionally, logistic factors related to surgery scheduling, the distance a patient lives from the health care center, and availability of support after patient discharge also play a role.
The decision to split patients into early and late cohorts based on median time to cranioplasty was made during study design and prior to data collection. This decision was made to reduce the risk of bias that would have occurred if a cut point was selected based on clinical factor(s). Ten weeks was selected as the cut point only after all the data had been gathered; therefore, the data collector was blinded to whether an individual patient would be in the early or late cohort.
An inherent study bias is the difference in cohort baseline characteristics. Although the cohorts were similarly matched in terms of age, sex, and cranioplasty type, there were differences. There were more than 3 times as many patients with ruptured AVMs in the early cohort (27.0% early, 8.1% late, p = 0.0325) and fewer patients with ischemic strokes (32.4% early, 45.9% late, p = 0.2334), intraparenchymal hemorrhages (13.5% early, 21.6% late, p = 0.3594), or venous sinus thromboses (0% early, 5.4% late, p = 0.4932). Unfortunately, the small numbers of patients with any one of these conditions make meaningful interpretation of data difficult. Therefore, we elected to include all patients with vascular causes of increased intracranial pressure requiring craniectomy in the study.
Our study is also limited by the risk of bias inherent to retrospective cohort investigations. This study was powered to detect an absolute difference of approximately 8% in the overall complication rate between the early and late cohorts. That our results show no statistically significant difference in complication rates between the cohorts does not necessarily equate with equivalence.
Conclusions
In this retrospective study of patients with hemor- rhage or ischemic stroke undergoing decompressive craniectomy, early cranioplasty (< 10 weeks from craniectomy) was associated with a higher overall complication rate than late cranioplasty (≥ 10 weeks from craniectomy), but this difference was not statistically significant.
Patients with a VP shunt at the time of cranioplasty were at higher risk for complications regardless of timing. Older patients (≥ 65 years of age) were at no higher risk than younger patients. Use of subgaleal surgical drains at the time of surgery did not increase the risk of infection or decrease the risk of hematoma.
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